These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7877240)

  • 1. Re: "Thrombolysis with tissue-plasminogen activator: results with a high-dose transthrombus technique". Thrombolysis Study Group.
    Braithwaite BD
    J Vasc Surg; 1995 Mar; 21(3):540. PubMed ID: 7877240
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombolysis with tissue-plasminogen activator: results with a high-dose transthrombus technique.
    Ward AS; Andaz SK; Bygrave S
    J Vasc Surg; 1994 Mar; 19(3):503-8. PubMed ID: 8126864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing trends in thrombolytic therapy for lower limb ischaemia.
    Andaz S; Scurr J
    Int Angiol; 1994 Jun; 13(2):93-5. PubMed ID: 7963882
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspirin improves the outcome of intra-arterial thrombolysis with tissue plasminogen activator. Thrombolysis Study Group.
    Braithwaite BD; Jones L; Yusuf SW; Dawson K; Berridge DC; Davies E; Bowyer R; Treska V; Earnshaw JJ
    Br J Surg; 1995 Oct; 82(10):1357-8. PubMed ID: 7489163
    [No Abstract]   [Full Text] [Related]  

  • 5. Percutaneous site-specific pharmacomechanical thrombolysis- thrombectomy system for bilateral acute limb ischemia.
    Gupta R; Gautam A; Hennebry TA
    J Invasive Cardiol; 2011 Feb; 23(2):81-3. PubMed ID: 21297206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolysis in high risk patients.
    McCall J; Gleeson FV; McGann G; Dawson K; Platts AD; Hamilton G
    Clin Radiol; 1992 May; 45(5):298-301. PubMed ID: 1516336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral thrombolysis with tissue plasminogen activator. Results of two treatment regimens.
    Ward AS; Andaz SK; Bygrave S
    Arch Surg; 1994 Aug; 129(8):861-5. PubMed ID: 8048859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial.
    Ann Surg; 1994 Sep; 220(3):251-66; discussion 266-8. PubMed ID: 8092895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choice of agent for peripheral thrombolysis.
    Earnshaw JJ; Scott DJ; Horrocks M; Baird RN
    Br J Surg; 1993 Jan; 80(1):25-7. PubMed ID: 8428284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of thrombolytic therapy with urokinase or recombinant tissue plasminogen activator for peripheral arterial occlusion: a comprehensive compilation of published work.
    Ouriel K; Kandarpa K
    J Endovasc Ther; 2004 Aug; 11(4):436-46. PubMed ID: 15298504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) in acute lower limb ischaemia.
    Flis V; Kobilica N; Bergauer A; Mrdža B; Milotič F; Štirn B
    J Int Med Res; 2011; 39(3):1107-12. PubMed ID: 21819745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolysis or peripheral arterial surgery: phase I results. TOPAS Investigators.
    Ouriel K; Veith FJ; Sasahara AA
    J Vasc Surg; 1996 Jan; 23(1):64-73; discussion 74-5. PubMed ID: 8558744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective randomized trial of high-dose bolus versus low-dose tissue plasminogen activator infusion in the management of acute limb ischaemia. Thrombolysis Study Group.
    Braithwaite BD; Buckenham TM; Galland RB; Heather BP; Earnshaw JJ
    Br J Surg; 1997 May; 84(5):646-50. PubMed ID: 9171752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tenecteplase in peripheral embolic disease.
    Bannerjee AK; Dastidar DG
    Indian Heart J; 2010; 62(4):313-5. PubMed ID: 21280470
    [No Abstract]   [Full Text] [Related]  

  • 15. Choice of agent for peripheral thrombolysis.
    Andaz S; Shields D
    Br J Surg; 1993 Jul; 80(7):944. PubMed ID: 8369947
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombolysis for acute lower limb ischaemia--a prospective, randomised, multicentre study comparing two strategies.
    Plate G; Jansson I; Forssell C; Weber P; Oredsson S
    Eur J Vasc Endovasc Surg; 2006 Jun; 31(6):651-60. PubMed ID: 16427339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The limited applicability of thrombolysis.
    Norgren L
    Eur J Vasc Surg; 1991 Jun; 5(3):361. PubMed ID: 1907572
    [No Abstract]   [Full Text] [Related]  

  • 18. Results of a prospective, randomized trial of surgery versus thrombolysis for occluded lower extremity bypass grafts.
    Comerota AJ; Weaver FA; Hosking JD; Froehlich J; Folander H; Sussman B; Rosenfield K
    Am J Surg; 1996 Aug; 172(2):105-12. PubMed ID: 8795509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolysis in critical ischaemia.
    Lonsdale RJ; Makin GS; Wenham PW; Hopkinson BR
    Eur J Vasc Surg; 1991 Jun; 5(3):361. PubMed ID: 1907573
    [No Abstract]   [Full Text] [Related]  

  • 20. Intraarterial catheter-directed thrombolysis: urokinase versus tissue plasminogen activator.
    Cinà CS; Goh RH; Chan J; Kenny B; Evans G; Rawlinson J; Gill G
    Ann Vasc Surg; 1999 Nov; 13(6):571-5. PubMed ID: 10541608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.